Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Wondering what percentage of your income to invest for retirement? This guide helps you determine the right amount to secure your financial future.
16,277 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
OpenAI has filed confidential IPO paperwork with the SEC, signaling a public listing could be on the horizon. The mov...
Investors often wonder if buying before a stock split makes sense. This guide explains the mechanics, the CrowdStrike...
SpaceX's IPO hype is hard to ignore, but there are four solid concerns investors should weigh before buying in. This ...
As Switzerland heads to the polls on a population cap, the country’s biotech and food giants warn that limiting immig...
Palantir rode the AI wave to big gains, but recent performance has paused. This guide analyzes whether palantir stock...
MercadoLibre reports 40% year-over-year growth fueled by fintech expansion and a resilient e-commerce network in Lati...
The market spotlight shifted to united states antimony stock after a notable insider purchase sparked a rally. This a...
Taiwan Semiconductor Manufacturing sits at the heart of today’s chip supply chain. This article breaks down why it’s ...
A surge of quantum milestones in 2026 is fueling talk that could commercially useful quantum machines may arrive soon...
Global policymakers wrestle with ai sovereignty as the economy and everyday life increasingly rely on frontier AI. Th...
SpaceX has fallen roughly a third from its peak, sparking questions about its trajectory. This article outlines four ...